首页> Oncoimmunology> Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jaquelyn T,Zoine

第一单位： Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.;Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, GA, USA.

作者： Jaquelyn T,Zoine ^[1] ; Kristopher A,Knight ^[2] ; Lauren C,Fleischer ^[3] ; Kathryn S,Sutton ^[4] ; Kelly C,Goldsmith ^[4] ; Christopher B,Doering ^[2] ; H Trent,Spencer ^[2]

作者单位： Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.;Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, GA, USA. ^[1] Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. ^[2] Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.;Molecular and Systems Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, GA, USA. ^[3] Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.;Children's Healthcare of Atlanta, Atlanta, GA, USA. ^[4]

关键词 dinutuximab neuroblastoma targeted immunotherapy temozolomide γδ T cells

DOI 10.1080/2162402X.2019.1593804

PMID 31413905

发布时间 2026-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交